
--- Page 1 ---
510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION
DECISION SUMMARY
ASSAY ONLY TEMPLATE
A. 510(k) Number:
k060645
B. Purpose for Submission:
New document
C. Measurand:
The Roche Preciset DAT Plus I and Roche Cfas DAT Qualitative Plus - calibrators
for amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone,
Methaqualone, opiates, phencyclidine and propoxyphene.
The Roche Preciset DAT Plus II - calibrator for amphetamines, benzodiazepines,
cannabinoids and opiates.
D. Type of Test:
Not Applicable
E. Applicant:
Roche Diagnostics Corp.
F. Proprietary and Established Names:
Preciset DAT Plus I, Preciset DAT Plus II, and CFAS DAT Qualitative Plus
Calibrators
G. Regulatory Information:
Product Code Classification Regulation Section Panel
Calibrators, Drug Class II 21 CFR 862.3200, 91 CLINICAL
Mixture (DKB) Clinical toxicology TOXICOLOGY
calibrator. (TX)
H. Intended Use:
1. Intended use(s):
1

[Table 1 on page 1]
	Product Code			Classification			Regulation Section			Panel	
Calibrators, Drug
Mixture (DKB)			Class II			21 CFR 862.3200,
Clinical toxicology
calibrator.			91 CLINICAL
TOXICOLOGY
(TX)		

--- Page 2 ---
See below indication(s) for use.
2. Indication(s) for use:
The Preciset DAT Plus I calibrators are designed for the calibration of the Roche
assays for drugs of abuse in human urine on automated clinical chemistry
analyzers.
The Preciset DAT Plus II calibrators are designed for the calibration of the Roche
assays for drugs of abuse in human urine on automated clinical chemistry
analyzers.
The Cfas DAT Qualitative Plus calibrator is designed for the qualitative
calibration of the Roche assays for drugs of abuse in human urine on automated
clinical chemistry analyzers.
3. Special conditions for use statement(s):
Prescription use.
4. Special instrument requirements:
Roche/Hitachi 911/912/917/MODULAR P analyzers
COBAS Integra 400/400plus/700/800
I. Device Description:
Roche Preciset DAT Plus I calibrators contain a mixture of 10 different drugs,
prepared by quantitative addition of drug or drug metabolite to drug-free human
urine. Drugs included are amphetamines, barbiturates, benzodiazepines,
cannabinoids, methadone, methaqualone, opiates, phencyclidine, and propoxyphene.
The calibrator set contains up to six levels for each drug contained in bottles 1-6.
Bottle 1 is negative (drug free) human urine, followed by bottles 2-6 containing
increasing amounts of each drug in a multi-analyte mixture. Drug or drug metabolite
and their respective target levels are as follows:
Amphetamines: 0, 250, 500, 1000, 3000, 5000 (ng/mL)
Barbiturates: 0, 100, 200, 400 (ng/mL) [no 5th and 6th level]
Benzodiazepines: 0, 150, 300, 600, 1000, 3000 (ng/mL)
Cannabinoids: 0, 20, 50, 100, 200, 300 (ng/mL)
Cocaine: 0, 75, 150, 300, 1000, 5000 (ng/mL)
Methadone: 0, 150, 300, 600, 2000) (ng/mL) [no 6th level]
Methaqualone: 0, 150, 300, 600 (ng/mL) [no 5th and 6th level]
Opiates: 0, 600, 1000, 2000, 4000, 8000 (ng/mL)
PCP: 0, 12.5, 25.0, 50.0 (ng/mL) [no 5th and 6th level]
2

--- Page 3 ---
Propoxyphene: 0, 150, 300, 600 (ng/mL) [no 5th and 6th level]
Roche Preciset DAT Plus II calibrators contain a mixture of 4 different drugs,
prepared by quantitative addition of drug or drug metabolite to drug-free human
urine. Drugs included are amphetamines, benzodiazepines, cannabinoids, and
opiates. The calibrator set contains up to six levels for each drug contained in
bottles 1-6. Bottle 1 is negative (drug free) human urine, followed by bottles 2-6
containing increasing amounts of each drug in a multi-analyte mixture. Drug or
drug metabolite and their respective target levels are as follows:
Amphetamines: 0, 150, 300, 600, 1000, 2000 (ng/mL)
Benzodiazepines: 0, 50, 100, 200, 400, 1000 (ng/mL)
Cannabinoids: 0, 10, 20, 40, 100 (ng/mL) [no 6th level]
Opiates: 0, 150, 300, 600, 1000, 2000 (ng/mL)
Roche Cfas DAT Qualitative Plus calibrator contains a mixture of 10 different
drugs, prepared by quantitative addition of drug or drug metabolite to drug-free
human urine. Drugs included are amphetamines, barbiturates, benzodiazepines,
cannabinoids, methadone, Methaqualone, opiates phencyclidine and
propoxyphene. The calibrator set contains a single level for each drug in a drug
mixture. Drugs or drug metabolites and their respective target levels are as
follows:
Amphetamines: 500 (ng/mL)
Barbiturates: 200 (ng/mL)
Benzodiazepines: 300 (ng/mL)
Cannabinoids: 50 (ng/mL)
Cocaine: 150 (ng/mL)
Methadone: 300 (ng/mL)
Methaqualone: 50 (ng/mL)
Opiates: 2000 (ng/mL)
Phencyclidine: 25 (ng/mL)
Propoxyphene: 300 (ng/mL)
J. Substantial Equivalence Information:
k031775 - Preciset DAT Plus I
Predicate k033306: Preciset DAT Plus II and Cfas DAT
Qualitative Plus
Describe the item being compared
The Roche Preciset DAT Plus I, Preciset DAT Plus II and Cfas DAT Qualitative Plus multianalyte
calibrators are substantially equivalent to the currently marketed Roche Preciset DAT Plus I,
Preciset DAT Plus II and Cfas DAT Qualitative Plus multianalyte calibrators, manufactured for
Roche Diagnostics and cleared in the following 510(k) submissions: K031775: Preciset DAT Plus I
K033306: Preciset DAT Plus II and Cfas DAT Qualitative Plus. The Preciset DAT Plus I and Preciset
DAT Plus II calibrators are designed for the calibration of the Roche assays for drugs of abuse in
human urine on automated clinical chemistry analyzers. The Cfas DAT Qualitative Plus calibrator is
designed for the qualitative calibration of the Roche assays for drugs of abuse in human urine on
automated clinical chemistry analyzers.
3

[Table 1 on page 3]
	k031775 - Preciset DAT Plus I
k033306: Preciset DAT Plus II and Cfas DAT
Qualitative Plus
Predicate	
	
Describe the item being compared	
The Roche Preciset DAT Plus I, Preciset DAT Plus II and Cfas DAT Qualitative Plus multianalyte
calibrators are substantially equivalent to the currently marketed Roche Preciset DAT Plus I,
Preciset DAT Plus II and Cfas DAT Qualitative Plus multianalyte calibrators, manufactured for
Roche Diagnostics and cleared in the following 510(k) submissions: K031775: Preciset DAT Plus I
K033306: Preciset DAT Plus II and Cfas DAT Qualitative Plus. The Preciset DAT Plus I and Preciset
DAT Plus II calibrators are designed for the calibration of the Roche assays for drugs of abuse in
human urine on automated clinical chemistry analyzers. The Cfas DAT Qualitative Plus calibrator is
designed for the qualitative calibration of the Roche assays for drugs of abuse in human urine on
automated clinical chemistry analyzers.	

--- Page 4 ---
Similarites
Feature Preciset DAT Plus I, Preciset Roche Preciset DAt Plis I,
DAT Plus II and Cfas DAT Preciset DAT Plus II and Cfas
Qualitative Plus Calibrators DAT Qualitative Plus
(Predicate Device) Calibrator
Indications for Use Preciset DAT Plus I Preciset DAT Plus I
The Preciset DAT Plus I The Preciset DAT Plus I
calibrators are designed for the calibrators are designed for the
calibration of the Roche assays calibration of the Roche assays
for drugs of abuse in human for drugs of abuse in human
urine on automated clinical urine on automated clinical
chemistry analyzers. chemistry analyzers.
Preciset DAT Plus II Preciset DAT Plus II
The Preciset DAT Plus II The Preciset DAT Plus II
calibrators are designed for the calibrators are designed for the
calibration of the Roche assays calibration of the Roche assays
for drugs of abuse in human for drugs of abuse in human
urine on automated clinical urine on automated clinical
chemistry analyzers. chemistry analyzers.
Cfas DAT Qualitative Plus Cfas DAT Qualitative Plus
The Cfas DAT Qualitative Plus The Cfas DAT Qualitative Plus
calibrator is designed for the calibrator is designed for the
qualitative calibration of the qualitative calibration of the
Roche assays for drugs of abuse Roche assays for drugs of abuse
in human urine on automated in human urine on automated
clinical chemistry analyzers. clinical chemistry analyzers.
Type of Material Preciset Dat Plus I Preciset DAT Plus I
Liquid, ready to use calibrators, Liquid, ready to use calibrators,
consists of 6 levels, Calibrators consists of 6 levels, Calibrators
1-6. 1-6.
Cfas DAT Qualitative Plus Cfas DAT Qualitative Plus
Liquid, ready to use calibrator, Liquid, ready to use calibrator,
consists of a single level. consists of a single level.
Matrix Human urine with stabilizers and Human urine with stabilizers and
preservatives. preservatives.
Packaging Preciset DAT Plus I Preciset DAT Plus I
Calibrators 1-6: 5 ml each level Calibrators 1-6: 5 ml each level
Preciset DAT Plus II Preciset DAT Plus II
Calibrators 1-6 5 ml each level Calibrators 1-6: 5 ml each level
4

[Table 1 on page 4]
Similarites		
Feature	Preciset DAT Plus I, Preciset
DAT Plus II and Cfas DAT
Qualitative Plus Calibrators
(Predicate Device)	Roche Preciset DAt Plis I,
Preciset DAT Plus II and Cfas
DAT Qualitative Plus
Calibrator
Indications for Use	Preciset DAT Plus I
The Preciset DAT Plus I
calibrators are designed for the
calibration of the Roche assays
for drugs of abuse in human
urine on automated clinical
chemistry analyzers.
Preciset DAT Plus II
The Preciset DAT Plus II
calibrators are designed for the
calibration of the Roche assays
for drugs of abuse in human
urine on automated clinical
chemistry analyzers.
Cfas DAT Qualitative Plus
The Cfas DAT Qualitative Plus
calibrator is designed for the
qualitative calibration of the
Roche assays for drugs of abuse
in human urine on automated
clinical chemistry analyzers.	Preciset DAT Plus I
The Preciset DAT Plus I
calibrators are designed for the
calibration of the Roche assays
for drugs of abuse in human
urine on automated clinical
chemistry analyzers.
Preciset DAT Plus II
The Preciset DAT Plus II
calibrators are designed for the
calibration of the Roche assays
for drugs of abuse in human
urine on automated clinical
chemistry analyzers.
Cfas DAT Qualitative Plus
The Cfas DAT Qualitative Plus
calibrator is designed for the
qualitative calibration of the
Roche assays for drugs of abuse
in human urine on automated
clinical chemistry analyzers.
Type of Material	Preciset Dat Plus I
Liquid, ready to use calibrators,
consists of 6 levels, Calibrators
1-6.
Cfas DAT Qualitative Plus
Liquid, ready to use calibrator,
consists of a single level.	Preciset DAT Plus I
Liquid, ready to use calibrators,
consists of 6 levels, Calibrators
1-6.
Cfas DAT Qualitative Plus
Liquid, ready to use calibrator,
consists of a single level.
Matrix	Human urine with stabilizers and
preservatives.	Human urine with stabilizers and
preservatives.
Packaging	Preciset DAT Plus I
Calibrators 1-6: 5 ml each level
Preciset DAT Plus II
Calibrators 1-6 5 ml each level	Preciset DAT Plus I
Calibrators 1-6: 5 ml each level
Preciset DAT Plus II
Calibrators 1-6: 5 ml each level

--- Page 5 ---
Cfas DAT Qualitative Plus Cfas DAT Qualitative Plus
Calibrator: 6 x 5 ml Calibrator: 6 x 5 ml
Differences
Feature Preciset DAT Plus I, Preciset Roche Preciset DAT Plus I,
DAT Plus II and Cfas DAT Preciset DAT Plus II and Cfas
Qualitative Plus Calibrators DAT Qualitative Plus
(Predicate Device) Calibrators
Calibrator Level Preciset DAT Plus I Preciset DAT Plus I
Amphetamines (d- Amphetamines (d-
methamphetamine): 0, 250, 500, methamphetamine): 0, 250, 500,
1000, 3000, 5000 (ng/mL) 1000, 3000, 5000 (ng/mL)
Barbiturates (Secobarbital): 0, Barbiturates (Secobarbital): 0,
100, 200, 400 (ng/mL) 100, 200, 400 (ng/mL)
Benzodiazepines (nordiazepam): Benzodiazepines (nordiazepam):
0, 150, 300, 600 (ng/mL) 0, 150, 300, 600, 1000, 3000
(ng/mL)
Cannabinoids (.9 TCH-COOH):
0, 20, 50, 100, 200, 300 (ng/mL) Cannabinoids (.9 TCH-COOH):
0, 20, 50, 100, 200, 300 (ng/mL)
Cocaine (benzoylecogonine): 0,
75, 150, 300, 1000, 5000 Cocaine (benzoylecogonine): 0,
(ng/mL) 75, 150, 300, 1000, 5000
(ng/mL)
Methadone (dl-methadone): 0,
150, 300, 600, 2000 (ng/mL) Methadone (dl-methadone): 0,
150, 300, 600, 2000 (ng/mL)
Opiates (d-morhpine): 0, 600,
1000, 2000, 4000, 8000 (ng/mL) Methaqualone (Methaqualone):
0, 150, 300, 600 (ng/mL)
PCP (phencyclidine): 0, 12.5,
25.0, 50.0 (ng/mL) Opiates (d-morhpine): 0, 600,
1000, 2000, 4000, 8000 (ng/mL)
Propoxyphene (propoxyphene):
0, 150, 300, 600 ng/mL) PCP (phencyclidine): 0, 12.5,
25.0, 50.0 (ng/mL)
Propoxyphene (propoxyphene):
0, 150, 300, 600 ng/mL)
Preciset DAT Plus II Preciset DAT Plus II
Benzodiazepine: (nordiazepam): Amphetamines (d-
0, 50, 100, 200, 400 ng/mL) no methamphetamine): 0, 150, 300,
level 6 600, 1000, 2000 (ng/mL)
5

[Table 1 on page 5]
	Cfas DAT Qualitative Plus
Calibrator: 6 x 5 ml			Cfas DAT Qualitative Plus
Calibrator: 6 x 5 ml		
Differences						
Feature		Preciset DAT Plus I, Preciset			Roche Preciset DAT Plus I,	
		DAT Plus II and Cfas DAT			Preciset DAT Plus II and Cfas	
		Qualitative Plus Calibrators			DAT Qualitative Plus	
		(Predicate Device)			Calibrators	
Calibrator Level	Preciset DAT Plus I
Amphetamines (d-
methamphetamine): 0, 250, 500,
1000, 3000, 5000 (ng/mL)
Barbiturates (Secobarbital): 0,
100, 200, 400 (ng/mL)
Benzodiazepines (nordiazepam):
0, 150, 300, 600 (ng/mL)
Cannabinoids (.9 TCH-COOH):
0, 20, 50, 100, 200, 300 (ng/mL)
Cocaine (benzoylecogonine): 0,
75, 150, 300, 1000, 5000
(ng/mL)
Methadone (dl-methadone): 0,
150, 300, 600, 2000 (ng/mL)
Opiates (d-morhpine): 0, 600,
1000, 2000, 4000, 8000 (ng/mL)
PCP (phencyclidine): 0, 12.5,
25.0, 50.0 (ng/mL)
Propoxyphene (propoxyphene):
0, 150, 300, 600 ng/mL)
Preciset DAT Plus II
Benzodiazepine: (nordiazepam):
0, 50, 100, 200, 400 ng/mL) no
level 6	Preciset DAT Plus I			Preciset DAT Plus I	
		Amphetamines (d-			Amphetamines (d-	
		methamphetamine): 0, 250, 500,			methamphetamine): 0, 250, 500,	
		1000, 3000, 5000 (ng/mL)			1000, 3000, 5000 (ng/mL)	
		Barbiturates (Secobarbital): 0,			Barbiturates (Secobarbital): 0,	
		100, 200, 400 (ng/mL)			100, 200, 400 (ng/mL)	
		Benzodiazepines (nordiazepam):			Benzodiazepines (nordiazepam):	
		0, 150, 300, 600 (ng/mL)			0, 150, 300, 600, 1000, 3000	
					(ng/mL)	
		Cannabinoids (.9 TCH-COOH):				
		0, 20, 50, 100, 200, 300 (ng/mL)			Cannabinoids (.9 TCH-COOH):	
					0, 20, 50, 100, 200, 300 (ng/mL)	
		Cocaine (benzoylecogonine): 0,				
		75, 150, 300, 1000, 5000			Cocaine (benzoylecogonine): 0,	
		(ng/mL)			75, 150, 300, 1000, 5000	
					(ng/mL)	
		Methadone (dl-methadone): 0,				
		150, 300, 600, 2000 (ng/mL)			Methadone (dl-methadone): 0,	
					150, 300, 600, 2000 (ng/mL)	
		Opiates (d-morhpine): 0, 600,				
		1000, 2000, 4000, 8000 (ng/mL)			Methaqualone (Methaqualone):	
					0, 150, 300, 600 (ng/mL)	
		PCP (phencyclidine): 0, 12.5,				
		25.0, 50.0 (ng/mL)			Opiates (d-morhpine): 0, 600,	
					1000, 2000, 4000, 8000 (ng/mL)	
		Propoxyphene (propoxyphene):				
		0, 150, 300, 600 ng/mL)			PCP (phencyclidine): 0, 12.5,	
					25.0, 50.0 (ng/mL)	
						
					Propoxyphene (propoxyphene):	
					0, 150, 300, 600 ng/mL)	
		Preciset DAT Plus II			Preciset DAT Plus II	
		Benzodiazepine: (nordiazepam):			Amphetamines (d-	
		0, 50, 100, 200, 400 ng/mL) no			methamphetamine): 0, 150, 300,	
		level 6			600, 1000, 2000 (ng/mL)	
						

--- Page 6 ---
Opiates (d-morphine): 0, 150, Benzodiazepine: (nordiazepam):
300, 600, 1000, 2000 (ng/mL) 0, 50, 100, 200, 400, 1000
ng/mL)
Cannabinoids (.9 THC-COOH):
0, 10, 20, 40, 100 (ng/mL)
Opiates (d-morphine): 0, 150,
300, 600, 1000, 2000 (ng/mL)
Cfas DAT Qualitative Plus
Cfas DAT Qualitative Plus
Amphetamines: 500
Barbiturates: 200 (ng/mL)
(ng/mL)
Benzodiazepines: 300
Barbiturates: 200 (ng/mL)
(ng/mL)
Benzodiazepines: 300
Cocaine: 150 (ng/mL)
(ng/mL)
Methadone: 300 (ng/mL)
Cannabinoids: 50 (ng/mL)
Opiates: 2000 (ng/mL)
Cocaine: 150 (ng/mL)
Phencyclidine: 25 (ng/mL)
Methadone: 300 (ng/mL)
Propoxyphene: 300
Methaqualone: 50 (ng/mL)
(ng/mL)
Opiates: 2000 (ng/mL)
Phencyclidine: 25 (ng/mL)
Propoxyphene: 300
(ng/mL)
K. Standard/Guidance Document Referenced (if applicable):
STANDARDS
Title and Reference Number
Medical devices - Application of risk management to medical devices (14971:2000)
GUIDANCE
6

[Table 1 on page 6]
	Opiates (d-morphine): 0, 150,
300, 600, 1000, 2000 (ng/mL)
Cfas DAT Qualitative Plus
Barbiturates: 200 (ng/mL)
Benzodiazepines: 300
(ng/mL)
Cocaine: 150 (ng/mL)
Methadone: 300 (ng/mL)
Opiates: 2000 (ng/mL)
Phencyclidine: 25 (ng/mL)
Propoxyphene: 300
(ng/mL)	Benzodiazepine: (nordiazepam):
0, 50, 100, 200, 400, 1000
ng/mL)
Cannabinoids (.9 THC-COOH):
0, 10, 20, 40, 100 (ng/mL)
Opiates (d-morphine): 0, 150,
300, 600, 1000, 2000 (ng/mL)
Cfas DAT Qualitative Plus
Amphetamines: 500
(ng/mL)
Barbiturates: 200 (ng/mL)
Benzodiazepines: 300
(ng/mL)
Cannabinoids: 50 (ng/mL)
Cocaine: 150 (ng/mL)
Methadone: 300 (ng/mL)
Methaqualone: 50 (ng/mL)
Opiates: 2000 (ng/mL)
Phencyclidine: 25 (ng/mL)
Propoxyphene: 300
(ng/mL)
K. Standard/Guidance Document Referenced (if applicable):		
STANDARDS		
Title and Reference Number		
Medical devices - Application of risk management to medical devices (14971:2000)		
		
GUIDANCE		

[Table 2 on page 6]
Opiates (d-morphine): 0, 150,
300, 600, 1000, 2000 (ng/mL)




Cfas DAT Qualitative Plus
Barbiturates: 200 (ng/mL)

Benzodiazepines: 300
(ng/mL)

Cocaine: 150 (ng/mL)

Methadone: 300 (ng/mL)

Opiates: 2000 (ng/mL)

Phencyclidine: 25 (ng/mL)

Propoxyphene: 300
(ng/mL)





[Table 3 on page 6]
Benzodiazepine: (nordiazepam):
0, 50, 100, 200, 400, 1000
ng/mL)
Cannabinoids (.9 THC-COOH):
0, 10, 20, 40, 100 (ng/mL)
Opiates (d-morphine): 0, 150,
300, 600, 1000, 2000 (ng/mL)

Cfas DAT Qualitative Plus
Amphetamines: 500
(ng/mL)

Barbiturates: 200 (ng/mL)

Benzodiazepines: 300
(ng/mL)

Cannabinoids: 50 (ng/mL)

Cocaine: 150 (ng/mL)

Methadone: 300 (ng/mL)

Methaqualone: 50 (ng/mL)

Opiates: 2000 (ng/mL)

Phencyclidine: 25 (ng/mL)

Propoxyphene: 300
(ng/mL)

--- Page 7 ---
Document Title Office Division Web Page
Guidance for Industry - Abbreviated http://www.fda.gov/cdrh/ode/calibrator.html
510(k) Submissions for In Vitro OIVD
Diagnostic Calibrators; Final
L. Test Principle:
Not applicable
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
Not applicable
b. Linearity/assay reportable range:
Not applicable
c. Traceability, Stability, Expected values (controls, calibrators, or methods):
Analyte concentrations in the Preciset DAT Plus I, Preciset DAT plus II and
Cfas DAT Qualitative Plus calibrator sets are traceable to and verified by a
primary reference method, specifically GC-MS.
d. Detection limit:
Not applicable
e. Analytical specificity:
Not applicable
f. Assay cut-off:
Not applicable
2. Comparison studies:
a. Method comparison with predicate device:
7

[Table 1 on page 7]
Document Title	Office	Division	Web Page
Guidance for Industry - Abbreviated
510(k) Submissions for In Vitro
Diagnostic Calibrators; Final	OIVD		http://www.fda.gov/cdrh/ode/calibrator.html
			
			

--- Page 8 ---
Not applicable
b. Matrix comparison:
Not applicable
3. Clinical studies:
a. Clinical Sensitivity:
Not applicable
b. Clinical specificity:
Not applicable
c. Other clinical supportive data (when a. and b. are not applicable):
4. Clinical cut-off:
Not applicable
5. Expected values/Reference range:
Not applicable
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a
substantial equivalence decision.
8